| Blood exosomes endowed with magnetic and targeting properties for cancer therapy H Qi, C Liu, L Long, Y Ren, S Zhang, X Chang, X Qian, H Jia, J Zhao, ... ACS nano 10 (3), 3323-3333, 2016 | 412 | 2016 |
| Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner K Zhang, X Sun, X Zhou, L Han, L Chen, Z Shi, A Zhang, M Ye, Q Wang, ... Oncotarget 6 (1), 537, 2015 | 242 | 2015 |
| Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma X Qian, L Long, Z Shi, C Liu, M Qiu, J Sheng, P Pu, X Yuan, Y Ren, ... Biomaterials 35 (7), 2322-2335, 2014 | 191 | 2014 |
| Multistage delivery nanoparticle facilitates efficient CRISPR/dCas9 activation and tumor growth suppression in vivo Q Liu, K Zhao, C Wang, Z Zhang, C Zheng, Y Zhao, Y Zheng, C Liu, Y An, ... Advanced Science 6 (1), 1801423, 2019 | 142 | 2019 |
| Efficient delivery of nerve growth factors to the central nervous system for neural regeneration D Xu, D Wu, M Qin, LR Nih, C Liu, Z Cao, J Ren, X Chen, Z He, W Yu, ... Advanced Materials 31 (33), 1900727, 2019 | 114 | 2019 |
| Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy Q Zhan, K Yi, H Qi, S Li, X Li, Q Wang, Y Wang, C Liu, M Qiu, X Yuan, ... Theranostics 10 (17), 7889, 2020 | 109 | 2020 |
| Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy L Han, C Liu, H Qi, J Zhou, J Wen, D Wu, D Xu, M Qin, J Ren, Q Wang, ... Advanced Materials 31 (19), 1805697, 2019 | 102 | 2019 |
| Biodegradable polymer with effective near‐Infrared‐II absorption as a photothermal agent for deep tumor therapy Y Yu, D Tang, C Liu, Q Zhang, L Tang, Y Lu, H Xiao Advanced Materials 34 (4), 2105976, 2022 | 100 | 2022 |
| A bioinspired platform for effective delivery of protein therapeutics to the central nervous system D Wu, M Qin, D Xu, L Wang, C Liu, J Ren, G Zhou, C Chen, F Yang, Y Li, ... Advanced Materials 31 (18), 1807557, 2019 | 91 | 2019 |
| Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy Y Ren, R Wang, L Gao, K Li, X Zhou, H Guo, C Liu, D Han, J Tian, Q Ye, ... Journal of Controlled Release 228, 74-86, 2016 | 87 | 2016 |
| An antioxidant enzyme therapeutic for COVID‐19 M Qin, Z Cao, J Wen, Q Yu, C Liu, F Wang, J Zhang, F Yang, Y Li, ... Advanced Materials 32 (43), 2004901, 2020 | 84 | 2020 |
| Efficient delivery of therapeutic miRNA nanocapsules for tumor suppression C Liu, J Wen, Y Meng, K Zhang, J Zhu, Y Ren, X Qian, X Yuan, Y Lu, ... Advanced Materials (Deerfield Beach, Fla.) 27 (2), 292-297, 2015 | 84 | 2015 |
| Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice J Wen, D Wu, M Qin, C Liu, L Wang, D Xu, HV Vinters, Y Liu, E Kranz, ... Nature biomedical engineering 3 (9), 706-716, 2019 | 78 | 2019 |
| Self‐sacrificially degradable pseudo‐semiconducting polymer nanoparticles that integrate NIR‐II fluorescence bioimaging, photodynamic immunotherapy, and photo‐activated … D Tang, Y Yu, J Zhang, X Dong, C Liu, H Xiao Advanced Materials 34 (34), 2203820, 2022 | 77 | 2022 |
| Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma K Huang, X Liu, Y Li, Q Wang, J Zhou, Y Wang, F Dong, C Yang, Z Sun, ... Advanced Science 6 (17), 1900782, 2019 | 68 | 2019 |
| A multifunctional composite hydrogel that rescues the ROS microenvironment and guides the immune response for repair of osteoporotic bone defects Q Chen, J Li, F Han, Q Meng, H Wang, Q Wei, Z Li, F Li, E Xie, X Qin, ... Advanced Functional Materials 32 (27), 2201067, 2022 | 62 | 2022 |
| NanoRNP overcomes tumor heterogeneity in cancer treatment Q Liu, J Cai, Y Zheng, Y Tan, Y Wang, Z Zhang, C Zheng, Y Zhao, C Liu, ... Nano Letters 19 (11), 7662-7672, 2019 | 49 | 2019 |
| ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity K Zhang, S Zhu, Y Liu, X Dong, Z Shi, A Zhang, C Liu, L Chen, J Wei, P Pu, ... Cancer letters 357 (1), 404-411, 2015 | 48 | 2015 |
| A hematoporphyrin-based delivery system for drug resistance reversal and tumor ablation Y Ren, R Wang, Y Liu, H Guo, X Zhou, X Yuan, C Liu, J Tian, H Yin, ... Biomaterials 35 (8), 2462-2470, 2014 | 45 | 2014 |
| Nanotherapeutics overcoming the blood-brain barrier for glioblastoma treatment L Tang, Y Feng, S Gao, Q Mu, C Liu Frontiers in Pharmacology 12, 786700, 2021 | 40 | 2021 |
Kang Chunsheng or Chun-sheng KangTianjin Medical UniversityGeverifieerd e-mailadres voor tmu.edu.cn
